Provocative Angiography, Followed by Therapeutic Interventions, in the Management of Hard-To-Diagnose Gastrointestinal Bleeding.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 15 5 2020
medline: 10 2 2021
entrez: 15 5 2020
Statut: ppublish

Résumé

Despite significant advances in imaging and endoscopic diagnostic techniques, adequate localization of gastrointestinal bleeding (GIB) can be challenging. Provocative angiography (PROVANGIO) has not been part of the standard diagnostic algorithms yet. We sought to examine the ability of PROVANGIO to identify the bleeding source when conventional radiography fails. Patients undergoing PROVANGIO for GIB during 2008-2014 were retrospectively included. Demographics and periprocedural patient characteristics were recorded. PROVANGIO was performed in a multidisciplinary setting, involving interventional radiology, surgery and anesthesiology teams, ready to intervene in case of uncontrolled bleeding. The procedure included conventional angiography of the celiac, superior and inferior mesenteric arteries (SMA, IMA) followed by a stepwise bleeding provocation with anticoagulating, vasodilating and/or thrombolytic agent administration, combined with angiography. Twenty-three PROVANGIO were performed. Patients were predominantly male (15, 65.2%), and hematochezia was the most common presenting symptom (12, 52.2%). Patients with a positive PROVANGIO had lower Charlson comorbidity index (1 vs. 7, p = 0.009) and were less likely to have a prior history of GIB (14.3% vs. 87.5%, p = 0.001). PROVANGIO localized bleeding in 7 (30%) patients. In 6 out of 7 patients, the bleeding source was identified in the SMA and, in one case, in the IMA distribution. The bleeding was controlled angiographically in four cases, endoscopically in one case and surgically in the remaining two. No complications related to PROVANGIO were detected. In our series, PROVANGIO safely identified the bleeding source, and provided that necessary safeguards are put into place, we recommend incorporating it in the diagnostic algorithms for GIB management.

Sections du résumé

BACKGROUND
Despite significant advances in imaging and endoscopic diagnostic techniques, adequate localization of gastrointestinal bleeding (GIB) can be challenging. Provocative angiography (PROVANGIO) has not been part of the standard diagnostic algorithms yet. We sought to examine the ability of PROVANGIO to identify the bleeding source when conventional radiography fails.
METHODS
Patients undergoing PROVANGIO for GIB during 2008-2014 were retrospectively included. Demographics and periprocedural patient characteristics were recorded. PROVANGIO was performed in a multidisciplinary setting, involving interventional radiology, surgery and anesthesiology teams, ready to intervene in case of uncontrolled bleeding. The procedure included conventional angiography of the celiac, superior and inferior mesenteric arteries (SMA, IMA) followed by a stepwise bleeding provocation with anticoagulating, vasodilating and/or thrombolytic agent administration, combined with angiography.
RESULTS
Twenty-three PROVANGIO were performed. Patients were predominantly male (15, 65.2%), and hematochezia was the most common presenting symptom (12, 52.2%). Patients with a positive PROVANGIO had lower Charlson comorbidity index (1 vs. 7, p = 0.009) and were less likely to have a prior history of GIB (14.3% vs. 87.5%, p = 0.001). PROVANGIO localized bleeding in 7 (30%) patients. In 6 out of 7 patients, the bleeding source was identified in the SMA and, in one case, in the IMA distribution. The bleeding was controlled angiographically in four cases, endoscopically in one case and surgically in the remaining two. No complications related to PROVANGIO were detected.
CONCLUSIONS
In our series, PROVANGIO safely identified the bleeding source, and provided that necessary safeguards are put into place, we recommend incorporating it in the diagnostic algorithms for GIB management.

Identifiants

pubmed: 32405731
doi: 10.1007/s00268-020-05545-8
pii: 10.1007/s00268-020-05545-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2944-2949

Références

Oakland K (2019) Changing epidemiology and etiology of upper and lower gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 42–43:101610
doi: 10.1016/j.bpg.2019.04.003
Billingham RP (1997) The conundrum of lower gastrointestinal bleeding. Surg Clin North Am 77(1):241–252
doi: 10.1016/S0039-6109(05)70542-9
Farrell JJ, Friedman LS (2005) Review article: the management of lower gastrointestinal bleeding. Aliment Pharmacol Ther 21(11):1281–1298
doi: 10.1111/j.1365-2036.2005.02485.x
Longstreth GF (1997) Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 92(3):419–424
pubmed: 9068461
Johnston C, Tuite D, Pritchard R et al (2007) Use of provocative angiography to localize site in recurrent gastrointestinal bleeding. Cardiovasc Intervent Radiol 30(5):1042–1046
doi: 10.1007/s00270-007-9107-5
Wu M, Klass D, Strovski E et al (2013) Aberrant celio-mesenteric supply of the splenic flexure: provoking a bleed. World J Gastroenterol 19(39):6679–6682
doi: 10.3748/wjg.v19.i39.6679
Zurkiya O, Walker TG (2015) Angiographic evaluation and management of nonvariceal gastrointestinal hemorrhage. AJR Am J Roentgenol 205(4):753–763
doi: 10.2214/AJR.15.14803
Kim CY, Suhocki PV, Miller MJ Jr et al (2010) Provocative mesenteric angiography for lower gastrointestinal hemorrhage: results from a single-institution study. J Vasc Interv Radiol 21(4):477–483
doi: 10.1016/j.jvir.2009.11.021
Nusbaum M, Baum S, Blakemore WS (1969) Clinical experience with the diagnosis and management of gastrointestinal hemorrhage by selective mesenteric catheterization. Ann Surg 170(3):506–514
doi: 10.1097/00000658-196909010-00018
Lin S, Rockey DC (2005) Obscure gastrointestinal bleeding. Gastroenterol Clin North Am 34(4):679–698
doi: 10.1016/j.gtc.2005.08.005
Malden ES, Hicks ME, Royal HD et al (1998) Recurrent gastrointestinal bleeding: use of thrombolysis with anticoagulation in diagnosis. Radiology 207(1):147–151
doi: 10.1148/radiology.207.1.9530310
Ryan JM, Key SM, Dumbleton SA et al (2001) Nonlocalized lower gastrointestinal bleeding: provocative bleeding studies with intraarterial tPA, heparin, and tolazoline. J Vasc Interv Radiol 12(11):1273–1277
doi: 10.1016/S1051-0443(07)61551-6
Velmahos GC, Toutouzas KG, Vassiliu P et al (2002) A prospective study on the safety and efficacy of angiographic embolization for pelvic and visceral injuries. J Trauma 53(2):303–308
doi: 10.1097/00005373-200208000-00019
Rosch J, Keller FS, Wawrukiewicz AS et al (1982) Pharmacoangiography in the diagnosis of recurrent massive lower gastrointestinal bleeding. Radiology 145(3):615–619
doi: 10.1148/radiology.145.3.6983087
Koval G, Benner KG, Rosch J et al (1987) Aggressive angiographic diagnosis in acute lower gastrointestinal hemorrhage. Dig Dis Sci 32(3):248–253
doi: 10.1007/BF01297049
Bloomfeld RS, Smith TP, Schneider AM et al (2000) Provocative angiography in patients with gastrointestinal hemorrhage of obscure origin. Am J Gastroenterol 95(10):2807–2812
doi: 10.1111/j.1572-0241.2000.03191.x
Shetzline MA, Suhocki P, Dash R et al (2000) Provocative angiography in obscure gastrointestinal bleeding. South Med J 93(12):1205–1208
doi: 10.1097/00007611-200093120-00013
Mernagh JR, O’Donovan N, Somers S et al (2001) Use of heparin in the investigation of obscure gastrointestinal bleeding. Can Assoc Radiol J 52(4):232–235
pubmed: 11512295
Widlus DM, Salis AI (2007) Reteplase provocative visceral arteriography. J Clin Gastroenterol 41(9):830–833
doi: 10.1097/01.mcg.0000225640.83275.23
Kariya S, Nakatani M, Ono Y et al (2020) Provocative angiography for lower gastrointestinal bleeding. Jpn J Radiol 38(3):248–255
doi: 10.1007/s11604-019-00909-0

Auteurs

Nikolaos Kokoroskos (N)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA. nickkokordoc@gmail.com.

Leon Naar (L)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Thomas Peponis (T)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Myriam Martinez (M)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Mohamad El Moheb (M)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Majed El Hechi (M)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Osaid Alser (O)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Eva Fuentes (E)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

George Velmahos (G)

Division of Trauma, Department of Surgery, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 810, Boston, MA, 02114, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH